108 related articles for article (PubMed ID: 12218294)
1. Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24.
Schindelmann S; Windisch J; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Tumour Biol; 2002; 23(3):139-45. PubMed ID: 12218294
[TBL] [Abstract][Full Text] [Related]
2. Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.
Sauer G; Kurzeder C; Grundmann R; Kreienberg R; Zeillinger R; Deissler H
Oncol Rep; 2003; 10(2):405-10. PubMed ID: 12579280
[TBL] [Abstract][Full Text] [Related]
3. CD24 is a marker for human breast carcinoma.
Fogel M; Friederichs J; Zeller Y; Husar M; Smirnov A; Roitman L; Altevogt P; Sthoeger ZM
Cancer Lett; 1999 Aug; 143(1):87-94. PubMed ID: 10465342
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.
Mahauad-Fernandez WD; DeMali KA; Olivier AK; Okeoma CM
Breast Cancer Res; 2014 Dec; 16(6):493. PubMed ID: 25499888
[TBL] [Abstract][Full Text] [Related]
5. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
[TBL] [Abstract][Full Text] [Related]
6. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
8. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.
Brandt B; Mikesch JH; Simon R; Rötger A; Kemming D; Schier K; Sauter G; Bürger H
Biochem Biophys Res Commun; 2005 Apr; 329(1):318-23. PubMed ID: 15721309
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of CD24 core polypeptide molecule in normal rat tissues and human tumor cell lines.
Akashi T; Shirasawa T; Hirokawa K
Virchows Arch; 1994; 425(4):399-406. PubMed ID: 7820302
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M
Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632
[TBL] [Abstract][Full Text] [Related]
12. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
13. Differential mRNA display analysis of two related but functionally distinct rat insulinoma (RIN) cell lines: identification of CD24 and its expression in the developing pancreas.
Cram DS; McIntosh A; Oxbrow L; Johnston AM; DeAizpurua HJ
Differentiation; 1999 May; 64(4):237-46. PubMed ID: 10365441
[TBL] [Abstract][Full Text] [Related]
14. CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.
Bretz N; Noske A; Keller S; Erbe-Hofmann N; Schlange T; Salnikov AV; Moldenhauer G; Kristiansen G; Altevogt P
Clin Exp Metastasis; 2012 Jan; 29(1):27-38. PubMed ID: 21984372
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
16. Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes.
Leccia F; Nardone A; Corvigno S; Vecchio LD; De Placido S; Salvatore F; Veneziani BM
Cytometry A; 2012 Nov; 81(11):960-72. PubMed ID: 22791584
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of amino acid starvation-induced CD24 gene in MCF-7 human breast cancer cells.
Liu W; Vadgama JV
Int J Oncol; 2000 May; 16(5):1049-54. PubMed ID: 10762644
[TBL] [Abstract][Full Text] [Related]
18. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
[TBL] [Abstract][Full Text] [Related]
20. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
